ID | JOS-j.bmc.2021.116255 |
著者:名前 | |
著者:別形式 | Takao, Koichi / Takemura, Yuri / Nagai, Junko / Kamauchi, Hitoshi / Hoshi, Kaori / Mabashi, Ryo / Uesawa, Yoshihiro / Sugita, Yoshiaki |
著者:カナ | |
著者:所属 | 城西大学薬学部薬科学科生物有機化学研究室 / 城西大学薬学部薬科学科生物有機化学研究室 / 明治薬科大学医療分子解析学研究室 / 城西大学薬学部薬科学科生物有機化学研究室 / J城西大学薬学部薬科学科生物有機化学研究室 / 城西大学薬学部薬科学科生物有機化学研究室 / 明治薬科大学医療分子解析学研究室 / 城西大学薬学部薬科学科生物有機化学研究室 |
著者:所属(別形式) | Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry / Meiji Pharmaceutical University, Department of Medical Molecular Informatics / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry / Meiji Pharmaceutical University, Department of Medical Molecular Informatics / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, Laboratory of Bioorganic Chemistry |
著者版フラグ | author |
出版者 | Elsevier |
冊子ISSN | 09680896 |
電子ISSN | 14643391 |
掲載誌名 | |
巻 | 42 |
刊行年月 | 2021-07 |
開始ページ | 1 |
終了ページ | 9 |
コンテンツ作成日 | 2021-03-08 |
コンテンツ修正日 | 2021-05-28 |
コンテンツ登録日 | 2023-07-27 |
識別番号:DOI | info:doi/10.1016/j.bmc.2021.116255 |
識別番号:DOI(リンク) | |
PubMed番号 | 34119696 |
抄録 | A series of 3-styrylchromone derivatives was synthesized and evaluated for monoamine oxidase (MAO) A and B inhibitory activities. Most of all derivatives inhibited MAO-B selectively, except compound 21. Compound 19, which had a methoxy group at R2 on the chromone ring and chlorine at R4 on phenyl ring, potently inhibited MAO-B, with an IC50 value of 2.2 nM. Compound 1 showed the highest MAO-B selectivity, with a selectivity index of >3700. Further analysis of these compounds indicated that compounds 1 and 19 were reversible and mixed-type MAO-B inhibitors, suggesting that their mode of action may be through tight-binding inhibition to MAO-B.Quantitative structure–activity relationship (QSAR) analyses of the 3-styrylchromone derivatives were conducted using their pIC50 values, through Molecular Operating Environment (MOE) and Dragon. There were 1796 descriptors of MAO-B inhibitory activity, which showed significant correlations (P < 0.05). Further investigation of the 3-styrylchromone structures as useful scaffolds was performed through three-dimensional-QSAR studies using AutoGPA, which is based on the molecular field analysis algorithm using MOE. The MAO-B inhibitory activity model constructed using pIC50 value index exhibited a determination coefficients (R2) of 0.972 and a Leave-One-Out cross-validated determination coefficients (Q2) of 0.914.These data suggest that the 3-styrylchromone derivatives assessed herein may be suitable for the design and development of novel MAO inhibitors. |
キーワード | |
注記 | Article No.175068 |
言語 | eng |
資源タイプ | text |
ジャンル | |
フォーマット | application/pdf |
権利 | Copyright © 2021 Elsevier Ltd. |
このアイテムを表示する:本文(pdf) | ( 886.8KB) ダウンロード回数: 回 |
このアイテムを表示する:URI | |